## MTD: Mettler-Toledo International, I - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 1.1% below STRENGTH zone (4.0-10.0%); PEG 3.64 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-3.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($1391.71)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Capital Counsel LLC NY Cuts Stock Holdings in Mettler-Toledo International, Inc. $MTD**
- Source: MarketBeat | 20251201T143644 | Neutral | Relevance: 100%
- Capital Counsel LLC NY reduced its stake in Mettler-Toledo International, Inc. by 1.8% in Q2 2025, now owning 0.72% of the company's stock valued at $174,092,000. Despite this, other major institutional investors either increased their holdings significantly or made minor adjustments. Wall Street analysts maintain a "Hold" rating for Mettler-Toledo International with an average target price of $1,406.50, following recent positive earnings results.

**2. BLI Banque de Luxembourg Investments Sells 900 Shares of Mettler-Toledo International, Inc. $MTD**
- Source: MarketBeat | 20251130T083702 | Neutral | Relevance: 99%
- BLI Banque de Luxembourg Investments reduced its stake in Mettler-Toledo International, Inc. by selling 900 shares, bringing its total holdings to 8,000 shares valued at $9.47 million. Other institutional investors also adjusted their positions, and the company's stock experienced a slight dip despite reporting strong quarterly earnings that beat analyst estimates. Insider selling by CEO Patrick Kaltenbach and Gerry Keller was also noted, alongside updated price targets from several Wall Street analysts.

**3. Loomis Sayles & Co. L P Buys 12,671 Shares of Mettler-Toledo International, Inc. $MTD**
- Source: MarketBeat | 20251130T115126 | Neutral | Relevance: 98%
- Loomis Sayles & Co. L P increased its stake in Mettler-Toledo International, Inc. (NYSE:MTD) by 7.7%, purchasing an additional 12,671 shares. This brings their total holdings to 178,128 shares valued at approximately $209.3 million, representing 0.86% of the company. The article also details recent insider selling by the CEO and CFO, as well as updated analyst ratings and the company's strong financial performance.

**4. Tsai Capital Corp Makes New Investment in Mettler-Toledo International, Inc. $MTD**
- Source: MarketBeat | 20251130T134820 | Somewhat-Bullish | Relevance: 98%
- Tsai Capital Corp initiated a new position in Mettler-Toledo International (NYSE:MTD) during Q2 2025, purchasing 1,855 shares valued at approximately $2.18 million. This investment represents 1.6% of Tsai Capital Corp's portfolio, making MTD its 24th largest holding. The stock currently holds a "Hold" consensus rating from Wall Street analysts with a target price of $1,406.50, despite recent insider selling totaling $28.68 million.

**5. Mettler-Toledo International, Inc. $MTD Shares Acquired by Korea Investment CORP**
- Source: MarketBeat | 20251201T112202 | Somewhat-Bullish | Relevance: 98%
- Korea Investment CORP significantly increased its stake in Mettler-Toledo International, Inc. (MTD) by 21.3% in Q2, acquiring an additional 2,845 shares. This investment positions Korea Investment CORP as a notable holder with 16,202 shares valued at approximately $19.03 million. The article also details Mettler-Toledo's strong Q3 earnings, beating expectations with $11.15 EPS and $1.03 billion in revenue, alongside insider trading activities and recent analyst ratings.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Goldman Sachs | $1475 | $0 | 0% |
| 2025-12-02 | Morgan Stanley | $1550 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Goldman Sachs | init | Neutral |
| 2025-12-02 | Morgan Stanley | init | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 18 ($1.28M) |
| Sells | 6 ($0.98M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (+1.4%)
- Blackrock Inc.: 9.2% (-3.1%)
- State Street Corpora: 4.7% (-0.5%)
- Capital Internationa: 4.2% (+1.2%)
- Bank Of New York Mel: 4.0% (-9.0%)

### Key Risks

1. Valuation stretched: PEG 3.6x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.64 signals overvaluation risk, limited margin of safety. Forward P/E 32.1x stretched relative to 8% growth. Quality metrics strong (ROE 30%, ROA 20%, margin 21%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $29.0B |
| Beta | 1.40 |
| 52W Range | $946.69 - $1525.17 |
| Short Interest | 4.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.64 |
| Forward P/E | 32.1 |
| Current P/E | 34.8 |
| YoY Growth | 8.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 4.8% to 1.1% (-3.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.9pp (needs >4.0% for momentum thesis). MRS_5 (-1.4%) diverging from MRS_20 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (2.45), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.10% (CS: 64) | Neutral |
| RSI_14 | 60.2 | Neutral |
| MACD Histogram | 2.45 | Bullish |
| vs SMA20 | 1.022x | Above |
| vs SMA50 | 1.073x | Above |
| vs SMA200 | 1.184x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $1468.09
- **Stop Loss:** $1391.71 (5.2% risk)
- **Target:** $1544.47 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 9
- **Position Value:** $13,212.81
- **Portfolio %:** 13.21%
- **Risk Dollars:** $750.00
- **Risk Per Trade:** 0.75%
- **Modifiers:** L1 100% | L2 75% | Combined 0.75x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

### Earnings

**Next:** 2026-02-05 (Est: $12.80)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $10.66 | $11.15 | +4.6% |
| 2025Q2 | $9.60 | $10.09 | +5.1% |
| 2025Q1 | $7.88 | $8.19 | +3.9% |
| 2024Q4 | $11.72 | $12.41 | +5.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*